Cumulatively, our findings that APLP2 functions contribute to migration and metastasis, together with our previous discovery of the ability of beta-secretase inhibition to lessen pancreatic cancer cell growth [5], suggest that APLP2 could be a viable target for attacking pancreatic cancer. The gene discussed is APLP2; the disease is familial pancreatic carcinoma.